CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist

25.39
-0.09-0.35%

Market Closed Dec 20 15:00 CST

4.06BMarket Cap35.41P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-10.74%307.76M

52.12%277.33M

1.48%314.2M

-33.32%230.2M

-34.46%344.8M

-67.52%182.31M

-42.53%309.63M

-42.37%345.25M

-47.60%526.09M

-47.26%561.36M

Transactional financial assets

22.57%332.56M

2.95%382.03M

0.22%341.64M

41.38%396.41M

441.20%271.32M

--371.09M

276.04%340.9M

3,001.66%280.37M

--50.13M

----

Notes receivable and accounts receivable

-1.98%289.16M

-11.44%272.59M

-1.88%253.29M

-4.61%263.96M

38.62%295.01M

33.18%307.79M

40.77%258.15M

18.26%276.72M

-28.69%212.81M

-25.44%231.11M

-Accounts receivable

-1.98%289.16M

-11.44%272.59M

-1.88%253.29M

-4.61%263.96M

38.62%295.01M

33.18%307.79M

40.77%258.15M

18.26%276.72M

-27.10%212.81M

-20.41%231.11M

Other receivables (including interest and dividends)

-4.31%34.39M

-4.29%36.56M

0.04%35.9M

28.22%35.56M

337.82%35.94M

397.23%38.19M

994.83%35.88M

339.47%27.73M

-56.49%8.21M

-61.67%7.68M

-Other receivable

----

-4.29%36.56M

----

397.23%38.19M

----

339.47%27.73M

----

-61.67%7.68M

Advance payment

12.38%28.77M

3.85%30.82M

14.59%28.88M

5.30%12.08M

-15.38%25.6M

8.76%29.67M

-32.32%25.2M

-48.06%11.47M

69.03%30.25M

211.13%27.28M

Inventories

36.89%60.89M

79.99%72.23M

16.51%48.04M

31.02%48.47M

20.98%44.48M

-0.30%40.13M

-5.91%41.23M

-21.33%36.99M

-25.74%36.77M

0.51%40.25M

Receivable financing

-72.03%5.72M

-62.83%6.07M

-6.62%11.55M

-4.10%18.86M

202.27%20.45M

259.22%16.34M

113.60%12.37M

89.34%19.67M

--6.77M

--4.55M

Other current assets

-65.48%75.36M

-83.80%33.67M

-73.97%56.33M

1,113.07%224.41M

3,265.50%218.32M

3,348.85%207.89M

960.29%216.37M

-7.07%18.5M

35.60%6.49M

-82.52%6.03M

Total current assets

-9.66%1.13B

-6.88%1.11B

-12.09%1.09B

20.97%1.23B

43.12%1.26B

35.88%1.19B

34.26%1.24B

7.27%1.02B

-37.03%877.52M

-40.56%878.26M

Non Current assets

Other equity investment

1.35%740.51M

-10.84%703.53M

16.62%726.15M

29.86%684.31M

48.28%730.68M

54.13%789.03M

15.73%622.65M

-5.99%526.94M

-9.94%492.77M

-12.56%511.91M

Other non-current financial assets

0.25%74.32M

-0.02%74.26M

-2.21%75.03M

-2.31%74.95M

--74.14M

--74.27M

--76.73M

----

Long-term equity investment

-28.09%49.17M

-30.18%48.36M

-30.05%48.92M

-29.45%49.58M

-62.76%68.38M

-57.90%69.27M

-59.31%69.93M

-48.10%70.28M

126.68%183.63M

102.10%164.54M

Fixed assets

----

-10.47%207.85M

----

-9.40%232.16M

----

-5.82%245.68M

----

-4.83%256.24M

Constru in process

----

12.37%208.02M

----

35.72%185.12M

----

43.00%181.98M

----

133.90%136.41M

Intangible assets

-1.01%848.02M

-0.99%850.32M

-0.99%852.73M

5.15%854.64M

5.25%856.66M

5.52%858.86M

5.79%861.27M

-0.30%812.75M

-0.27%813.9M

-0.33%813.91M

Development expenditure

92.87%194.89M

112.01%178.28M

119.62%162.72M

26.15%149.82M

-21.92%101.04M

-33.72%84.09M

-12.14%74.09M

46.49%118.76M

388.73%129.42M

--126.87M

Goodwill

0.00%97.64M

Long deferred expense

-42.09%640.88K

-47.21%693.79K

-54.58%691.26K

-46.62%898.93K

18.52%1.11M

23.20%1.31M

26.84%1.52M

25.92%1.68M

7,082.21%933.69K

7,519.89%1.07M

Deferred tax assets

1,610.25%21.04M

2,567.70%23.44M

3,761.21%32.19M

2,870.53%32.27M

-85.14%1.23M

-89.92%878.49K

-89.95%833.77K

-87.88%1.09M

36.52%8.28M

37.15%8.72M

Usufruct assets

204.77%19.02M

-36.38%5.29M

-80.00%2.08M

-66.67%4.16M

-52.47%6.24M

-44.55%8.32M

-38.39%10.4M

-33.46%12.48M

-36.36%13.13M

104.01%15.01M

Other non current assets

135.38%402.07M

226.62%399.51M

227.61%396.09M

-26.66%192.2M

-47.01%170.82M

-62.07%122.32M

-61.68%120.9M

-17.14%262.07M

305.37%322.38M

415.23%322.5M

Total non current assets

13.52%2.86B

10.86%2.8B

18.79%2.8B

5.93%2.55B

1.93%2.52B

2.79%2.52B

-3.30%2.36B

-0.64%2.41B

20.53%2.47B

20.91%2.45B

Total assets

5.81%4B

5.16%3.91B

8.15%3.89B

10.40%3.78B

12.72%3.78B

11.51%3.72B

7.01%3.6B

1.59%3.42B

-2.75%3.35B

-4.99%3.33B

Liabilities

Current liabilities

Short term loan

19.91%103.05M

37.30%79.06M

341.98%126.75M

--96.93M

--85.94M

--57.59M

--28.68M

----

Notes payable and accounts payable

138.53%98.44M

229.32%107.09M

281.02%88.43M

71.16%82.97M

21.08%41.27M

27.99%32.52M

21.56%23.21M

3.72%48.47M

-2.59%34.08M

-62.71%25.41M

-Accounts payable

138.53%98.44M

229.32%107.09M

281.02%88.43M

71.16%82.97M

21.08%41.27M

27.99%32.52M

21.56%23.21M

3.72%48.47M

-2.59%34.08M

-62.71%25.41M

Contract liabilities

53.58%2.19M

89.47%3.4M

62.31%4.32M

122.03%6.49M

1.05%1.43M

31.78%1.79M

21.89%2.66M

142.73%2.92M

128.67%1.41M

-34.60%1.36M

Advance receipts

----

--36.23K

----

Salaries payable

12.69%23.74M

25.36%20.82M

13.96%17.44M

32.75%30.22M

20.78%21.07M

-5.31%16.61M

14.53%15.31M

-2.59%22.76M

0.15%17.44M

24.76%17.54M

Taxs payable

-79.47%7.76M

-88.79%3.26M

-95.15%1.93M

-90.68%3.69M

33.27%37.77M

17.92%29.04M

40.97%39.92M

44.94%39.57M

47.51%28.34M

11.99%24.63M

Other payable (including interest and dividends)

26.39%68.09M

55.71%132.18M

69.43%89.84M

88.39%94M

10.10%53.87M

74.42%84.89M

8.98%53.02M

2.59%49.9M

9.89%48.93M

-87.97%48.67M

-Dividend payable

----

52.39%47.69M

----

--31.3M

----

-Other payable

----

57.65%84.48M

----

10.11%53.59M

----

2.59%49.9M

----

-87.97%48.67M

Non current liabilities due within one year

162.00%16.19M

9.71%8.93M

2.92%9.02M

4.12%9.07M

-20.45%6.18M

6.07%8.14M

15.46%8.76M

16.14%8.71M

-5.07%7.77M

173.94%7.68M

Other current liabilities

-26.26%25.34K

-68.21%15.11K

-29.51%38.65K

26.16%30.41K

-72.85%34.37K

-4.45%47.51K

-64.68%54.83K

10.88%24.11K

57.64%126.57K

-81.61%49.72K

Total current liabilities

29.03%319.47M

53.82%354.74M

96.82%337.77M

87.62%323.39M

79.28%247.59M

84.02%230.62M

43.78%171.61M

11.37%172.36M

10.46%138.1M

-76.85%125.32M

Current liabilities

Long term loan

74.75%85.45M

26.72%64.1M

-20.00%40.42M

--43.78M

--48.9M

--50.58M

--50.52M

----

Deferred tax liabilities

-4.55%40.46M

-35.69%32.77M

-15.39%37.85M

-6.22%27.78M

21.85%42.39M

34.77%50.96M

7.76%44.73M

-34.19%29.62M

-12.30%34.79M

-16.86%37.81M

Long term deferred income

-15.79%20.71M

-16.97%21.63M

-18.02%22.56M

-18.96%23.49M

-3.35%24.59M

-3.17%26.05M

-3.00%27.52M

-2.86%28.98M

-18.70%25.44M

-17.86%26.91M

Lease liabilities

--12.55M

306.92%3.84M

----

-86.98%942.69K

-76.03%2.2M

-66.66%3.71M

-51.31%5.97M

61.96%7.24M

Total non current liabilities

37.36%159.17M

-4.82%122.35M

-19.32%100.82M

52.54%95.05M

75.03%115.88M

78.63%128.54M

58.05%124.97M

-27.52%62.31M

-20.46%66.21M

-13.00%71.96M

Total liabilities

31.69%478.64M

32.83%477.09M

47.88%438.59M

78.31%418.44M

77.90%363.47M

82.05%359.16M

49.47%296.58M

-2.52%234.68M

-1.89%204.31M

-68.38%197.28M

Shareholders equity

Paid-in capital

0.00%160M

Capital reserve funds

1.20%959.95M

-2.71%965.57M

-3.24%960.29M

-3.77%955.01M

-4.25%948.54M

0.37%992.46M

0.55%992.46M

0.74%992.46M

0.08%990.63M

1.41%988.81M

Surplus reserve funds

0.00%80M

Retained profit

3.41%2.04B

4.66%2B

7.20%2.01B

6.44%1.97B

6.21%1.97B

4.43%1.91B

1.83%1.88B

3.04%1.85B

3.87%1.85B

4.85%1.83B

Less:Treasury stock

54.55%55.92M

-36.95%78.59M

-70.97%36.19M

0.00%124.64M

23.65%124.64M

Other composite income

94.13%25.09M

-112.19%-7.62M

-76.09%11.61M

19.20%-26.5M

119.68%12.93M

226.52%62.53M

278.10%48.54M

-304.51%-32.8M

-237.43%-65.69M

-478.02%-49.42M

Shareholders equity without minority interests

2.26%3.2B

1.23%3.12B

3.70%3.14B

4.58%3.06B

8.30%3.13B

6.81%3.08B

3.94%3.03B

1.29%2.93B

0.82%2.89B

0.42%2.89B

Minority interests

11.97%312.99M

13.04%310.52M

14.61%307.63M

14.47%302.44M

10.63%279.52M

10.06%274.7M

9.19%268.41M

9.27%264.22M

-31.19%252.67M

2,447.86%249.59M

Total shareholder equity

3.06%3.52B

2.20%3.43B

4.58%3.45B

5.40%3.36B

8.49%3.41B

7.07%3.36B

4.35%3.3B

1.90%3.19B

-2.81%3.15B

8.73%3.14B

Total liabilityies and equity

5.81%4B

5.16%3.91B

8.15%3.89B

10.40%3.78B

12.72%3.78B

11.51%3.72B

7.01%3.6B

1.59%3.42B

-2.75%3.35B

-4.99%3.33B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Huaxing Certified Public Accountants Firm (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-10.74%307.76M	52.12%277.33M	1.48%314.2M	-33.32%230.2M	-34.46%344.8M	-67.52%182.31M	-42.53%309.63M	-42.37%345.25M	-47.60%526.09M	-47.26%561.36M
Transactional financial assets	22.57%332.56M	2.95%382.03M	0.22%341.64M	41.38%396.41M	441.20%271.32M	--371.09M	276.04%340.9M	3,001.66%280.37M	--50.13M	----
Notes receivable and accounts receivable	-1.98%289.16M	-11.44%272.59M	-1.88%253.29M	-4.61%263.96M	38.62%295.01M	33.18%307.79M	40.77%258.15M	18.26%276.72M	-28.69%212.81M	-25.44%231.11M
-Accounts receivable	-1.98%289.16M	-11.44%272.59M	-1.88%253.29M	-4.61%263.96M	38.62%295.01M	33.18%307.79M	40.77%258.15M	18.26%276.72M	-27.10%212.81M	-20.41%231.11M
Other receivables (including interest and dividends)	-4.31%34.39M	-4.29%36.56M	0.04%35.9M	28.22%35.56M	337.82%35.94M	397.23%38.19M	994.83%35.88M	339.47%27.73M	-56.49%8.21M	-61.67%7.68M
-Other receivable	----	-4.29%36.56M	----	----	----	397.23%38.19M	----	339.47%27.73M	----	-61.67%7.68M
Advance payment	12.38%28.77M	3.85%30.82M	14.59%28.88M	5.30%12.08M	-15.38%25.6M	8.76%29.67M	-32.32%25.2M	-48.06%11.47M	69.03%30.25M	211.13%27.28M
Inventories	36.89%60.89M	79.99%72.23M	16.51%48.04M	31.02%48.47M	20.98%44.48M	-0.30%40.13M	-5.91%41.23M	-21.33%36.99M	-25.74%36.77M	0.51%40.25M
Receivable financing	-72.03%5.72M	-62.83%6.07M	-6.62%11.55M	-4.10%18.86M	202.27%20.45M	259.22%16.34M	113.60%12.37M	89.34%19.67M	--6.77M	--4.55M
Other current assets	-65.48%75.36M	-83.80%33.67M	-73.97%56.33M	1,113.07%224.41M	3,265.50%218.32M	3,348.85%207.89M	960.29%216.37M	-7.07%18.5M	35.60%6.49M	-82.52%6.03M
Total current assets	-9.66%1.13B	-6.88%1.11B	-12.09%1.09B	20.97%1.23B	43.12%1.26B	35.88%1.19B	34.26%1.24B	7.27%1.02B	-37.03%877.52M	-40.56%878.26M
Non Current assets
Other equity investment	1.35%740.51M	-10.84%703.53M	16.62%726.15M	29.86%684.31M	48.28%730.68M	54.13%789.03M	15.73%622.65M	-5.99%526.94M	-9.94%492.77M	-12.56%511.91M
Other non-current financial assets	0.25%74.32M	-0.02%74.26M	-2.21%75.03M	-2.31%74.95M	--74.14M	--74.27M	--76.73M	--76.73M	----	----
Long-term equity investment	-28.09%49.17M	-30.18%48.36M	-30.05%48.92M	-29.45%49.58M	-62.76%68.38M	-57.90%69.27M	-59.31%69.93M	-48.10%70.28M	126.68%183.63M	102.10%164.54M
Fixed assets	----	-10.47%207.85M	----	----	----	-9.40%232.16M	----	-5.82%245.68M	----	-4.83%256.24M
Constru in process	----	12.37%208.02M	----	----	----	35.72%185.12M	----	43.00%181.98M	----	133.90%136.41M
Intangible assets	-1.01%848.02M	-0.99%850.32M	-0.99%852.73M	5.15%854.64M	5.25%856.66M	5.52%858.86M	5.79%861.27M	-0.30%812.75M	-0.27%813.9M	-0.33%813.91M
Development expenditure	92.87%194.89M	112.01%178.28M	119.62%162.72M	26.15%149.82M	-21.92%101.04M	-33.72%84.09M	-12.14%74.09M	46.49%118.76M	388.73%129.42M	--126.87M
Goodwill	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M	0.00%97.64M
Long deferred expense	-42.09%640.88K	-47.21%693.79K	-54.58%691.26K	-46.62%898.93K	18.52%1.11M	23.20%1.31M	26.84%1.52M	25.92%1.68M	7,082.21%933.69K	7,519.89%1.07M
Deferred tax assets	1,610.25%21.04M	2,567.70%23.44M	3,761.21%32.19M	2,870.53%32.27M	-85.14%1.23M	-89.92%878.49K	-89.95%833.77K	-87.88%1.09M	36.52%8.28M	37.15%8.72M
Usufruct assets	204.77%19.02M	-36.38%5.29M	-80.00%2.08M	-66.67%4.16M	-52.47%6.24M	-44.55%8.32M	-38.39%10.4M	-33.46%12.48M	-36.36%13.13M	104.01%15.01M
Other non current assets	135.38%402.07M	226.62%399.51M	227.61%396.09M	-26.66%192.2M	-47.01%170.82M	-62.07%122.32M	-61.68%120.9M	-17.14%262.07M	305.37%322.38M	415.23%322.5M
Total non current assets	13.52%2.86B	10.86%2.8B	18.79%2.8B	5.93%2.55B	1.93%2.52B	2.79%2.52B	-3.30%2.36B	-0.64%2.41B	20.53%2.47B	20.91%2.45B
Total assets	5.81%4B	5.16%3.91B	8.15%3.89B	10.40%3.78B	12.72%3.78B	11.51%3.72B	7.01%3.6B	1.59%3.42B	-2.75%3.35B	-4.99%3.33B
Liabilities
Current liabilities
Short term loan	19.91%103.05M	37.30%79.06M	341.98%126.75M	--96.93M	--85.94M	--57.59M	--28.68M	----	----	----
Notes payable and accounts payable	138.53%98.44M	229.32%107.09M	281.02%88.43M	71.16%82.97M	21.08%41.27M	27.99%32.52M	21.56%23.21M	3.72%48.47M	-2.59%34.08M	-62.71%25.41M
-Accounts payable	138.53%98.44M	229.32%107.09M	281.02%88.43M	71.16%82.97M	21.08%41.27M	27.99%32.52M	21.56%23.21M	3.72%48.47M	-2.59%34.08M	-62.71%25.41M
Contract liabilities	53.58%2.19M	89.47%3.4M	62.31%4.32M	122.03%6.49M	1.05%1.43M	31.78%1.79M	21.89%2.66M	142.73%2.92M	128.67%1.41M	-34.60%1.36M
Advance receipts	----	----	----	----	--36.23K	----	----	----	----	----
Salaries payable	12.69%23.74M	25.36%20.82M	13.96%17.44M	32.75%30.22M	20.78%21.07M	-5.31%16.61M	14.53%15.31M	-2.59%22.76M	0.15%17.44M	24.76%17.54M
Taxs payable	-79.47%7.76M	-88.79%3.26M	-95.15%1.93M	-90.68%3.69M	33.27%37.77M	17.92%29.04M	40.97%39.92M	44.94%39.57M	47.51%28.34M	11.99%24.63M
Other payable (including interest and dividends)	26.39%68.09M	55.71%132.18M	69.43%89.84M	88.39%94M	10.10%53.87M	74.42%84.89M	8.98%53.02M	2.59%49.9M	9.89%48.93M	-87.97%48.67M
-Dividend payable	----	52.39%47.69M	----	----	----	--31.3M	----	----	----	----
-Other payable	----	57.65%84.48M	----	----	----	10.11%53.59M	----	2.59%49.9M	----	-87.97%48.67M
Non current liabilities due within one year	162.00%16.19M	9.71%8.93M	2.92%9.02M	4.12%9.07M	-20.45%6.18M	6.07%8.14M	15.46%8.76M	16.14%8.71M	-5.07%7.77M	173.94%7.68M
Other current liabilities	-26.26%25.34K	-68.21%15.11K	-29.51%38.65K	26.16%30.41K	-72.85%34.37K	-4.45%47.51K	-64.68%54.83K	10.88%24.11K	57.64%126.57K	-81.61%49.72K
Total current liabilities	29.03%319.47M	53.82%354.74M	96.82%337.77M	87.62%323.39M	79.28%247.59M	84.02%230.62M	43.78%171.61M	11.37%172.36M	10.46%138.1M	-76.85%125.32M
Current liabilities
Long term loan	74.75%85.45M	26.72%64.1M	-20.00%40.42M	--43.78M	--48.9M	--50.58M	--50.52M	----	----	----
Deferred tax liabilities	-4.55%40.46M	-35.69%32.77M	-15.39%37.85M	-6.22%27.78M	21.85%42.39M	34.77%50.96M	7.76%44.73M	-34.19%29.62M	-12.30%34.79M	-16.86%37.81M
Long term deferred income	-15.79%20.71M	-16.97%21.63M	-18.02%22.56M	-18.96%23.49M	-3.35%24.59M	-3.17%26.05M	-3.00%27.52M	-2.86%28.98M	-18.70%25.44M	-17.86%26.91M
Lease liabilities	--12.55M	306.92%3.84M	----	----	----	-86.98%942.69K	-76.03%2.2M	-66.66%3.71M	-51.31%5.97M	61.96%7.24M
Total non current liabilities	37.36%159.17M	-4.82%122.35M	-19.32%100.82M	52.54%95.05M	75.03%115.88M	78.63%128.54M	58.05%124.97M	-27.52%62.31M	-20.46%66.21M	-13.00%71.96M
Total liabilities	31.69%478.64M	32.83%477.09M	47.88%438.59M	78.31%418.44M	77.90%363.47M	82.05%359.16M	49.47%296.58M	-2.52%234.68M	-1.89%204.31M	-68.38%197.28M
Shareholders equity
Paid-in capital	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M
Capital reserve funds	1.20%959.95M	-2.71%965.57M	-3.24%960.29M	-3.77%955.01M	-4.25%948.54M	0.37%992.46M	0.55%992.46M	0.74%992.46M	0.08%990.63M	1.41%988.81M
Surplus reserve funds	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M	0.00%80M
Retained profit	3.41%2.04B	4.66%2B	7.20%2.01B	6.44%1.97B	6.21%1.97B	4.43%1.91B	1.83%1.88B	3.04%1.85B	3.87%1.85B	4.85%1.83B
Less:Treasury stock	54.55%55.92M	-36.95%78.59M	-36.95%78.59M	-36.95%78.59M	-70.97%36.19M	0.00%124.64M	0.00%124.64M	0.00%124.64M	0.00%124.64M	23.65%124.64M
Other composite income	94.13%25.09M	-112.19%-7.62M	-76.09%11.61M	19.20%-26.5M	119.68%12.93M	226.52%62.53M	278.10%48.54M	-304.51%-32.8M	-237.43%-65.69M	-478.02%-49.42M
Shareholders equity without minority interests	2.26%3.2B	1.23%3.12B	3.70%3.14B	4.58%3.06B	8.30%3.13B	6.81%3.08B	3.94%3.03B	1.29%2.93B	0.82%2.89B	0.42%2.89B
Minority interests	11.97%312.99M	13.04%310.52M	14.61%307.63M	14.47%302.44M	10.63%279.52M	10.06%274.7M	9.19%268.41M	9.27%264.22M	-31.19%252.67M	2,447.86%249.59M
Total shareholder equity	3.06%3.52B	2.20%3.43B	4.58%3.45B	5.40%3.36B	8.49%3.41B	7.07%3.36B	4.35%3.3B	1.90%3.19B	-2.81%3.15B	8.73%3.14B
Total liabilityies and equity	5.81%4B	5.16%3.91B	8.15%3.89B	10.40%3.78B	12.72%3.78B	11.51%3.72B	7.01%3.6B	1.59%3.42B	-2.75%3.35B	-4.99%3.33B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Huaxing Certified Public Accountants Firm (Special General Partnership)	--	--	--	Huaxing Certified Public Accountants Firm (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

Investment Theme

Specialized, Special and New

Intraday+2.45%

Civil-military Integration

Intraday+1.03%

603590 Beijing Konruns Pharmaceutical

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow